Sage Rhino Capital’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Sell
24,760
-611
-2% -$5.23K 0.05% 213
2025
Q4
$155K Buy
25,371
+1,575
+7% +$9.4K 0.03% 298
2025
Q3
$123K Buy
23,796
+9,714
+69% +$55.8K 0.02% 288
2025
Q2
$83.5K Sell
14,082
-2,562
-15% -$15.4K 0.02% 270
2025
Q1
$137K Buy
16,644
+2,585
+18% +$21.7K 0.03% 251
2024
Q4
$116K Buy
14,059
+3,928
+39% +$31.5K 0.03% 256
2024
Q3
$77.5K Sell
10,131
-2,492
-20% -$23K 0.02% 270
2024
Q2
$131K Buy
12,623
+1,724
+16% +$18.9K 0.03% 230
2024
Q1
$130K Buy
+10,899
New +$121K 0.03% 219

Other funds holding PTEN

Sage Rhino Capital's PTEN Position: Q1 2026 in Review

Sage Rhino Capital reduced its Patterson-UTI (PTEN) stake by 2.4% in Q1 2026, selling an estimated $5.23K and leaving 24,760 shares worth $268K. The position accounts for 0.05% of the portfolio, ranked #213.

Sage Rhino Capital first reported a position in PTEN in Q1 2024 and has held it in 9 quarters since. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Sage Rhino Capital held 24,760 shares of Patterson-UTI worth $268K as of Q1 2026.
  • Sage Rhino Capital sold 611 Patterson-UTI shares in Q1 2026, an estimated $5.23K.
  • Patterson-UTI made up 0.05% of Sage Rhino Capital's portfolio in Q1 2026, its #213 holding.
  • Sage Rhino Capital first reported a position in Patterson-UTI in Q1 2024 and has held it in 9 quarters since.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Sage Rhino Capital's 13F filing for Q1 2026, filed 28 Apr 2026.